ROHZAN ALTRE: Open Payments
NPI 1093005225 · WOODLAND HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 7 payments from 4 companies in 2025. Trend: 2023 $299 · 2024 $285 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $140 |
| Supernus Pharmaceuticals, Inc. | 1 | $124 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $49 |
Products named: INVEGA SUSTENNA, Qelbree, GARDASIL 9, NEFFY.
Industry payments across CA — which companies pay providers there.
